Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Adamis, Ascletis, Basilea, Biocon, Cansino, Carsgen, Edesa, Glaxosmithkline, Hutchmed, Imcyse, Immunome, Innovent, Jeil, Laekna Therapeutics Shanghai, Mitsubishi Tanabe Pharma America, Novavax, Pfizer, Rockwell Medical, SK, Viatris, Vir.